Evaluation of Levels of Some Inflammatory Cytokines in Preeclamptic Women in Owerri
Obioma Raluchukwu Emeka-Obi, Nancy C. Ibeh, Emmanuel I. Obeagu, Hope M. Okorie
Journal of Pharmaceutical Research International · pp. 53–65 · Published 25 Aug 2021
10.9734/jpri/2021/v33i42A32384Abstract
Preeclampsia is a serious and life-threatening pregnancy complication. In this study, the levels of inflammatory cytokines were measured in preeclamptic women in Owerri, Imo State. A total of 120 pregnant women aged 18-45 years at 20-40 weeks of pregnancy were recruited; 60 were preeclamptic women (test group) while 60 were normotensive pregnant women (control group). Preeclampsia was determined by the presence of ≥2+ protein in the urine using combi 2 dipstick for urinalysis and sphygmomanometer blood pressure reading of ≥ 140/90 mmHg. From the demographic data obtained in the studied subject through questionnaire, it showed that nulliparity and family history of high blood pressure were the most dominant risk factor of preeclampsia. The mean of the pro-inflammatory cytokines (IL-6 and TNF-α) in the test group were 4.33±1.42 pg/ml and 8.23±2.73 pg/ml while that of the control group were 3.38±1.22 pg/ml and 6.89±1.88 pg/ml. There was a significant increase in the pro-inflammatory cytokines of the preeclamptic women when compared to the control group. The mean of the anti-inflammatory cytokines (IL-10 & IL-4) of the group were 78.88±14.28 pg/ml and 27.92±7.22pg/ml while the control group was 91.39± 18.46 pg/ml and 31.25±6.90 pg/ml. There was a significant decrease in the result obtained from the test group when compared to the control group. The levels of the pro-inflammatory cytokines were higher than the levels of the anti-inflammatory cytokines of the test group when compared with the control group. Hence there is need to manage the disorder with an anti inflammatory drugs in order to enhance obstetric care, thereby reducing maternal mortality and morbidity that may occur from haemostatic abnormalities.
Cited by 5
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu · International Journal of Medical Sciences and Pharma Research · 2024
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu · Medicine · 2024
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu · Asian Journal of Dental and Health Sciences · 2024
Emmanuel Ifeanyi Obeagu · Clinical Journal of Obstetrics and Gynecology · 2024
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu · International Journal of Medical Sciences and Pharma Research · 2024
Related research
- Knowledge, Perception and Practice of Birth Preparedness and Complication Readiness among Pregnant Women Attending a Tertiary Healthcare Facility in Sokoto, Nigeria — shares topic coverage
- Prevalence of Malaria among Pregnant Women and Children Under Five Years in Abi Local Government Area, Cross River State, Nigeria — shares topic coverage
- Seroprevalence and Risk of Toxoplasma gondii Infection among Pregnant Women at Federal Teaching Hospital Gombe, Nigeria — shares topic coverage
- Seroprevalence and Risk of Primary Maternal HCMV Infection among Pregnant Women in Taiz City, Yemen — shares topic coverage
- Prevalence of HBV and HCV among Pregnant Women Attending Kumasi South Hospital (KSH), Ghana — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
5
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.